AVEG 038

A Multi-centered, Phase 1 Trial to Evaluate the Memory Responses to a Single Boosting Vaccination with ALVAC-HIV vCP205 in Volunteers Who Have Previously Received Poxvirus-based Vaccines

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) March 13, 2000
ALVAC-HIV MN120TMG strain (vCP205) Canarypox Env gp120, TM gp41, gag, protease B MN/LAI
ALVAC-HIV MN120TMG strain (vCP205) Viral Vector - Pox
USA 60